Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

A human germ line antibody light chain with hydrolytic properties associated with multimerization status.

Sharma V, Heriot W, Trisler K, Smider V.

J Biol Chem. 2009 Nov 27;284(48):33079-87. doi: 10.1074/jbc.M109.036087. Epub 2009 Oct 2.

2.

A metalloantibody that irreversibly binds a protein antigen.

Trisler K, Looger LL, Sharma V, Baker M, Benson DE, Trauger S, Schultz PG, Smider VV.

J Biol Chem. 2007 Sep 7;282(36):26344-53. Epub 2007 Jul 6.

3.
4.

Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.

Deb N, Goris M, Trisler K, Fowler S, Saal J, Ning S, Becker M, Marquez C, Knox S.

Clin Cancer Res. 1996 Aug;2(8):1289-97.

5.

Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel.

Ning S, Trisler K, Brown DM, Yu NY, Kanekal S, Lundsten MJ, Knox SJ.

Radiother Oncol. 1996 May;39(2):179-89.

PMID:
8735485
6.

Over-expression of Bcl-2 protects against apoptosis induced by the bioreductive cytotoxic drug SR4233 (Tirapazamine).

Gilbert MS, Rupnow BA, Ramirez DA, Trisler KD, Knox SJ.

Cell Death Differ. 1996 Apr;3(2):215-22.

PMID:
17180085
7.

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

Knox SJ, Goris ML, Trisler K, Negrin R, Davis T, Liles TM, Grillo-López A, Chinn P, Varns C, Ning SC, Fowler S, Deb N, Becker M, Marquez C, Levy R.

Clin Cancer Res. 1996 Mar;2(3):457-70.

Supplemental Content

Loading ...
Support Center